跳至主要内容
临床试验/NCT00180440
NCT00180440已完成不适用

INcidence Free SUrvival Before and After ICD Replacement

Guidant Corporation1 个研究点 分布在 1 个国家目标入组 528 人开始时间: 2002年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
528
试验地点
1

研究概览

简要总结

The INSURE trial is a multi-center, prospective trial to collect information about adequate ICD therapies in ICD patients before and after their first elective ICD replacement.

详细描述

The INSURE trial is a multi-center, prospective trial to collect information about adequate ICD therapies in ICD patients before & after their first elective ICD replacement. For this purpose all consecutive ICD patients will be included in the study, whose first implanted device is replaced due to ICD battery depletion (i.e. arrival at battery indicator ERI). ICD replacements due to other reasons can be included if duration of first ICD implantation was > 3 years. All patients included in the trial are regularly followed up until delivery of their first adequate ICD therapy. The collected data shall provide statistically valid information about the risk to patients who never have experienced adequate ICD therapy before the ICD replacement investigated in this study. In the future, these statistical risk data can give additional information to implanting physicians, such as whether an ICD replacement can eventually be omitted in those patients who are at very low risk for the occurrence of ICD therapies. All actually available GUIDANT ICDs with CE certificate can be implanted in this trial.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All elective ICD replacements due to battery depletion of the first ICD being implanted in the patient

排除标准

  • Non-availability to regular follow-up
  • Age < 18 years
  • Pregnancy

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验